Getpeakenergy.com

Bioenergy RIBOSE & Caffeine
Solution for
 Decreased Fatigue/Increased Alertness/Elevated Mood  Higher Sport Performance  Cognitive/Mental Health  Cardiovascular Health D-Ribose, or simply ribose, is an aldopentose (5-carbon monosaccharide with an aldehyde functional group)
which is used by all cells of the body. Ribose is an essential structural component of energy currency Adenosine triphosphate (ATP) as well as several other compounds that are critical to metabolism. Ribose also comprises the backbone of RNA and is related to DNA. Forming ribose in heart and muscle is a slow process which, in turn, delays energy recovery when energy pools have been depleted by disease or exercise. Ribose restores and maintains depleted energy reserves. Ribose is often marketed as a supplement for boosting energy and reducing fatigue in: post exercise (muscle cramping and soreness), fibromyalgia Ribose also increases cardiac efficiency, power output and tolerance to stress. Bioenergy RIBOSE is GRAS (absorption of 95% with peak blood levels found within 30-45 min). The recommended daily dose depends on the product benefit (e.g., up to 1.5g for energy, up to 7 g for physical performance and up to 10 g for cardiovascular and general health). Caffeine is a bitter, white crystalline xanthine alkaloid which is found in many plants such as coffee, tea, and to
a lesser extent chocolate derived from cocoa beans. Less commonly used sources of caffeine include the yerba
maté and guarana plants. Caffeine content in coffee is in the range of 40 to 100 mg/cup.
Soft drinks typically contain about 10 to 50 mg/240 ml and energy drinks such as Red
Bull® has 80 mg/per 250 ml. The disparity in experience and effects between the various
natural caffeine sources could be because plant sources of caffeine also contain widely
varying mixtures of other xanthine alkaloids theobromine and theophylline, and
polyphenols that can form insoluble complexes with caffeine. Caffeine from coffee or
other beverages is absorbed by the stomach and small intestine within 45 minutes of ingestion. In humans,
caffeine is a central nervous system stimulant, having the effect of temporarily warding off drowsiness, decreased
fatigue, increased awareness/alertness/attentiveness, and elevating one's mood. With these effects, caffeine is an
ergogenic (increasing a person's capability for mental or physical labor). Caffeine's principal mode of action is as
a nonselective antagonist of adenosine receptors in the brain. Caffeine is metabolized in the liver into three
primary dimethylxanthine metabolites: paraxanthine (84%), theobromine (12%), and theophylline (4%) which
also contribute to caffeine's effects. In healthy adults, caffeine's half-life is about 5 hours. Caffeine is the most
widely consumed legal and unregulated psychoactive substance but overdose (>300 mg/day) must be avoided.
Advantages of combining Bioenergy RIBOSE and Caffeine
There seems to be a logical synergy for combining ribose and reasonable doses of caffeine. Caffeine has been
proven to decreased fatigue, increased alertness and elevated mood while ribose helps make the energy and higher
sport performance. As a result, combination of caffeine and ribose should show combination of these effects and
possibly improved cognitive and mental health.
References
1. Van Gammeren D, D Falk, J Antonio. The effect of four weeks of ribose supplementation on body composition and exercise performance in healthy, young, male recreational bodybuilders: A double-blind placebo-controlled trial, Current Therapeutic Research 2002; 63(8): 486-495 2. Seifert JG, A Subhudi, M-X Fu, KL Riska, John JC, Shecterle LM, The role of ribose on oxidative stress during hypoxic exercise: A pilot study, Journal of Medicinal Food 12 (3), 2009, 690-693 3. Hellsen Y, L Skadhauge, J Bangsbo, Effect of ribose supplementation on resynthesis of Adenine Nucleotides after intermittent training in humans, Am. J. Phsiol Regul Integr Comp Physiol 2004; 286: R182-R188 4. Brault JJ, RLet al, Purine Salvage to Adenine Nucleotides in different skeletal muscle fiber types, J Appl Physiol 2001; 91:231-238 5. Willimson DL, PM Gallagher, MP Goddard, SW Trappe, Effects of ribose supplementation on Adenine Nucleotide concentration in skeletal muscle following high-intensity exercise, Med Sci Sport Exc 2001; 33 (5 suppl) 6. Dodd SL, Johnson, Fernholz, JA St. Cyr, The role of ribose in human skeletal muscle metabolism, Med Hypoth 2004; 62(5): 819-824 7. Peters, Josef M. (1967). "Factors Affecting Caffeine Toxicity: A Review of the Literature". The Journal of Clinical Pharmacology and the Journal of New Drugs (7): 131–141. 8. Griffin, R. J.; Griffin, J. (2003). "Caffeine ingestion and fluid balance: a review". Journal of human nutrition and dietetics 16 (6): 411
9. Armstrong LE, Casa DJ, Maresh CM, Ganio MS (2007). "Caffeine, fluid-electrolyte balance, temperature regulation, and exercise-heat
tolerance". Exerc. Sport Sci. Rev. 35 (3): 135–140.
10. Matissek, R (1997). "Evaluation of xanthine derivatives in chocolate: nutritional and chemical aspects". European Food Research and Technology 205 (3): 175–84.
11. Balentine D. A., Harbowy M. E. and Graham H. N. (1998). G Spiller. ed. Tea: the Plant and its Manufacture; Chemistry and Consumption of the Beverage. 12. "Caffeine". International Coffee Organization. 13. "Caffeine Content of Food and Drugs". Nutrition Action Health Newsletter. Center for Science in the Public Interest. December 1996. 14. Haskell, C. F. et. al. (2007). "A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guarana in humans". J Psychopharmacol 21 (1): 65–70.
15. Smit, H. J.; Gaffan, EA; Rogers, PJ (2004). "Methylxanthines are the psycho-pharmacologically active constituents of chocolate". Psychopharmacology 176 (3–4): 412–9.
16. Bolton, Ph.D., Sanford (1981). "Caffeine: Psychological Effects, Use and Abuse". Orthomolecular Psychiatry 10 (3): 202–211.
17. Bennett Alan Weinberg, Bonnie K. Bealer (2001). The world of caffeine. Routledge. p. 195.
18. John C. Evans (1992) Tea in China: The History of China's National Drink. Greenwood Press.
19. Yu, Lu (October 1995). The Classic of Tea: Origins & Rituals. Ecco Pr; Reissue edition.
20. Weinberg, BA; BK Bealer (2001). The World of Caffeine. Routledge.
21. Ted Wilson, N. J. Temple (2004). Beverages in Nutrition and Health. Humana Press. p. 172.
22. Nehlig, A; Daval, JL; Debry, G (1992). "Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic, and
psychostimulant effects". Brain Res Rev 17 (2): 139–70.
23. Liguori A, Hughes JR, Grass JA (1997). "Absorption and subjective effects of caffeine from coffee, cola and capsules". Pharmacol Biochem Behav 58 (3): 721–6.
24. Newton, R; et. al.(1981). "Plasma and salivary pharmacokinetics of caffeine in man". Eur. J. of Clinical Pharmacology 21 (1): 45–52
25. Meyer, FP; Canzler, E; Giers, H; Walther, H (1991). "Time course of inhibition of caffeine elimination in response to the oral depot
contraceptive agent Deposiston. Hormonal contraceptives and caffeine elimination". Zentralbl Gynakol 113 (6): 297–302.
26. Bolton, Ph.D., Sanford (1981). "Caffeine: Psychological Effects, Use and Abuse". Orthomolecular Psychiatry 10 (3): 202–11.
27. Fisone, G et al. (2004). "Caffeine as a psychomotor stimulant: mechanism of action". Cell Mol Life Sci 61 (7–8): 857–72.
28. Daly JW et al (1987). "Adenosine receptors: development of selective agonists and antagonists.". Prog Clin Biol Res. 230 (1): :41–63.
29. Latini, S; Pedata, F (2001). "Adenosine in the central nervous system: release mechanisms and extracellular concentrations.". J Neurochem
79 (3): 463–84
30. Addicott MA, et. al. (2009). "The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?". Hum Brain Mapp. 30 (10): 3102–14.
31. Basheer, R. et al (2004). "Adenosine and sleep-wake regulation.". Prog Neurobiol 73 (6): 379–96.
32. Huang, ZL; et. al. (2005). "Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nature Neurosci 8 (7)858–9.
33. Dews, P.B. (1984). Caffeine: Perspectives from Recent Research. Berlin: Springer-Valerag.
34. Rasmussen, JL; Gallino, M (1997). "Effects of caffeine on subjective reports of fatigue and arousal during mentally demanding activities".
Eur. J. of Clinical Pharmacology 37 (1): 61–90.
35. Graham, TE; Spriet, LL (1991). "Performance and metabolic responses to a high caffeine dose during prolonged exercise". J Appl Physiol 71 (6): 2292–8.
36. Trice, I; Haymes, EM (1995). "Effects of caffeine ingestion on exercise-induced changes during high-intensity, intermittent exercise". Int J Sport Nutr 5 (1): 37–44.
37. Holtzman SG et al (1991). "Role of adenosine receptors in caffeine tolerance". J. Pharmacol. Exp. Ther. 256 (1): 62–8.
38. Juliano et al. (2004). "A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and
associated features". Psychopharmacology 176 (1): 1–29.
39. Sawynok, J (1995). "Pharmacological rationale for the clinical use of caffeine". Drugs 49 (1): 37–50.
40. Mackay, DC; Rollins, JW (1989). "Caffeine and caffeinism". Journal of the Royal Naval Medical Service 75 (2): 65–7.
41. James, JE; Stirling, KP (1983). "Caffeine: A summary of some of the known and suspected deleterious effects of habitual use". British
Journal of Addiction 78 (3): 251–8.
42. Leson CL, McGuigan MA, Bryson SM (1988). "Caffeine overdose in an adolescent male". J. Toxicol. Clin. Toxicol. 26 (5-6): 407–15.
13840 Johnson Street NE Minneapolis, Minnesota 55304 1.877.4RIBOSE www.bioenergyribose.com

Source: http://getpeakenergy.com/wp-content/uploads/2015/02/Bioenergy-Caffeine-Study-2.pdf